Direct-to-consumer drug advertising has long been opposed by the American Medical Association — and now the Trump ...

The Phase 1 study is a randomized, double-blind, placebo-controlled, dose-escalation trial carried out in China, designed to evaluate the safety, tolerability, pharmacokinetics (PK), and ...

The ethics of direct-to-consumer ads from pharmaceutical companies is being debated as the FDA looks towards possibly banning them altogether.

Lower drug prices offered through direct-to-consumer websites like TrumpRx are failing to reach patients with commercial ...

Drug cartels in Mexico are not just criminal gangs; in many areas, they act like shadow governments. The moment has also ...

TrumpRx was unveiled this month as part of an effort to foster a more competitive marketplace for prescription drugs.

Thermo Fisher Scientific is reiterated as a 'buy' with a fair value estimate of $619 per share, reflecting confidence in its ...

GLP-1 cost pressure is now a talent retention issue. A new study found that 29% of employees would switch jobs for coverage.

The danger is that Washington takes the wrong lesson: That Mexico can handle the cartels on its own, if only it musters the ...

Small-cap stocks delivered solid gains in 2025, marking another year in which the Russell 2000 Growth Index (up 13.01%) outperformed the Russell 2000 Value Index (up 12.58%). Read more here.